Cytotoxic activity of nemorosone in neuroblastoma cells

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 6B, 2008, Pages 2598-2608

  Diaz Carballo D ^a   Malak, S ^b   Bardenheuer, W ^b   Freistuehler, M ^b   Reusch, H P ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Akt PKB; Apoptosis; Cell cycle; Clusia rosea; ERK1 2; Isobologram; MYCN; Nemorosone; Neuroblastoma

Indexed keywords

BENZOPHENONE DERIVATIVE; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MYCN PROTEIN, HUMAN; NEMOROSONE; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; RAF PROTEIN;

ARTICLE; CELL CYCLE; CELL DEATH; DNA DAMAGE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; DRUG SCREENING; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; IC 50; ISOLATION AND PURIFICATION; METABOLISM; NEUROBLASTOMA; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BENZOPHENONES; CASPASE 3; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; DNA DAMAGE; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; ENZYME ACTIVATION; HUMANS; INHIBITORY CONCENTRATION 50; MAP KINASE KINASE 1; MAP KINASE KINASE 2; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-RAF; SIGNAL TRANSDUCTION;

CLUSIA ROSEA;

EID: 48749131574     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00232.x     Document Type: Article

References (33)

1. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007 23 : 2106 20.
2. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol. 1997 19 : 93 101.
3. Vandesompele J, Michels E, De Preter K, Menten B, Schramm A, Eggert A, Ambros PF, Combaret V, Francotte N, Antonacci F, De Paepe A, Laureys G, Speleman F, Van Roy N. Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomics. Int J Cancer. 2007 122 : 1177 82.
4. Schwab M. Molecular cytogenetics of human neuroblastoma. Biochim Biophys Acta. 1992 1114 : 43 50.
5. Wenzel A, Schwab M. The mycN/max protein complex in neuroblastoma. Short review. Eur J Cancer. 1995 31A : 516 29.
6. Cole MD, McMahon SB. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene. 1999 18 : 2916 24.
7. Boon K, Caron HN, van Asperen R, Valentijn L, Hermus MC, van Sluis P, Roobeek I, Weis I, Voûte PA, Schwab M, Versteeg R. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J. 2001 20 : 1383 93.
8. Raetz EA, Kim MK, Moos P, Carlson M, Bruggers C, Hooper DK, Foot L, Liu T, Seeger R, Carroll WL. Identification of genes that are regulated transcriptionally by Myc in childhood tumors. Cancer. 2003 98 : 841 53.
9. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002 2 : 489 501.
10. Shu W, Guttentag S, Wang Z, Andl T, Ballard P, Lu MM Piccolo S, Birchmeier W, Whitsett JA, Millar SE, Morrisey EE. Wnt/beta-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal-distal patterning in the lung. Dev Biol. 2005 283 : 226 39.
11. Li Z, Zhang J, Liu Z, Woo CW, Thiele CJ. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death. Cell Death Differ. 2007 14 : 318 26.
12. Sugimoto T, Kuroda H, Horii Y, Moritake H, Tanaka T, Hattori S. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells. Jpn J Cancer Res. 2001 92 : 152 60.
13. Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol. 2001 11 : 272 80.
14. Takahashi-Yanaga F, Shiraishi F, Hirata M, Miwa Y, Morimoto S, Sasaguri T. Glycogen synthase kinase-3beta is tyro-sine-phosphorylated by MEK1 in human skin fibroblasts. Biochem Biophys Res Commun. 2004 316 : 411 25.
15. Shira Yaari, Jasmine Jacob-Hirsch, Ninette Amariglio, Ronit Haklai, Gideon Rechavi, Yoel Kloog. Disruption of Cooperation Between Ras and MycN in Human Neuroblastoma Cells Promotes Growth Arrest. Clin Cancer Res. 2005 11 : 4321 30.
16. Cuesta-Rubio O, Velez-Castro H, Frontana-Uribe BA, Cardenas J. Nemorosone, the major constituent of floral resins of Clusia rosea. Phytochemistry. 2001 57 : 279 83.
17. Diaz-Carballo D, Seeber S, Strumberg D, Hilger RA. Novel antitumoral compound isolated from Clusia rosea. Int J Clin Pharmacol Ther. 2003 41 : 622 33.
18. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990 82 : 1107 12.
19. Tsugita M, Tsuru S, Takasaki T, Shinomiya N, Kobayashi S, Hanyu F. Flowcytometric measurement of the cell cycle of experimental tumors: some devices for accurate measurement of pro-liferative activity. Oncology. 1991 48 : 343 56.
20. Chiao C, Carothers AM, Grunberger D, Solomon G, Preston GA, Barrett JC. Apoptosis and altered redox state induced by caffeic acid phenethyl ester {CAPE} in transformed rat fibroblast cells. Cancer Res. 1995 55 : 3576 83.
21. Steel GG, Peckham MJ. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol, Biol Phys. 1979 5 : 85 91.
22. Cuesta-Rubio O, Frontana-Uribe BA, Ramirez-Apan T, Cardenas J. Polyisoprenylated benzophenones in Cuban propolis; biological activity of nemorosone. Z Naturforsch. 2002 57 : 372 8.
23. Bottazzi ME, Zhu X, Bohmer RM, Assoian RK. Regulation of p21{cip1} expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J Cell Biol. 1999 146 : 1255 64.
24. Cip1} mRNA expression associated with DNA damage and repair in acute immune complex alveolitis in mice. Lab Invest. 1997 76 : 161 9.
25. Hong G, Kreuzer KN. An antitumor drug-induced topoisomerase cleavage complex blocks a bacteriophage T4 replication fork in vivo. Mol Cell Biol. 2000 20 : 594 603.
26. Meyerson M. Role of telomerase in normal and cancer cells. J Clin Oncol. 2000 18 : 2626 34.
27. Camps M, Nichols A, Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. Faseb J. 2000 14 : 6 16.
28. Durocher D, Jackson SP. DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? Curr Opin Cell Biol. 2001 13 : 225 31.
29. Cheng JQ, Lindsley CW, Cheng GZ, Yang H, Nicosia SV. The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene. 2005 24 : 7482 92.
30. Wallace EM, Lyssikatos JP, Yeh T, Winkler JD, Koch K. Progress towards therapeutic small molecule MEK inhibitors for use in cancer therapy. Curr Top Med Chem. 2005 5 : 215 29.
31. Tong L, Smyth D, Kerr C, Catterall J, Richards CD. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts. Cell Signal. 2004 16 : 1123 32.
32. Boyd KE, Farnham PJ. Identification of target genes of oncogenic transcription factors. Proc Soc Exp Biol Med. 1999 222 : 9 28.
33. Balasubramanyam K, Altaf M, Varier RA, Swaminathan V, Ravindran A, Sadhale PP, Kundu TK. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem. 2004 279 : 33716 26.